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We describe an extension of semiconductor fabric-
ation methods that creates individual » 200 mm
diameter aqueous pathways through human stratum
corneum at predetermined sites. Our hypothesis is
that spatially localized electroporation of the multi-
lamellar lipid bilayer membranes provides rapid
delivery of salicylic acid to the keratin within
corneocytes, leading to localized keratin disruption
and then to a microconduit. A microconduit pene-
trating the isolated stratum corneum supports a
volumetric ¯ow of order 0.01ml per s with a pres-
sure difference of only 0.01 atm (about 102 Pa). This
study provides a method for rapidly microengineer-
ing a pathway in the skin to interface future devices
for transdermal drug delivery and sampling of
biologically relevant ¯uids. Key words: keratolytic
agents/skin electroporation/stratum corneum/transdermal
drug delivery. J Invest Dermatol 116:40±49, 2001
D
rug delivery continues to be of great and growing
interest (Langer, 1998). Established delivery
methods involving oral and injectable routes
encounter signi®cant problems, such as high ®rst-
pass hepatic metabolism and patient compliance.
Minimally invasive transdermal intervention can avoid these
problems and is increasingly viewed as an attractive alternative
(Smith and Maibach, 1995; Guy, 1996; Schaefer and Redelmeier,
1996; Merino et al, 1997). Analyte extraction through the skin is
also being considered as a mean for analyte sampling (Tamada et al,
1995; Smith et al, 1999; Kost et al, 2000). Transdermal molecular
transport with temporal control would be valuable for both drug
delivery and analyte sensing; however, the practical handling and
obtrusiveness of present invasive transdermal delivery systems
severely restrict their use in many day to day applications (Wouters
and Dinh, 1997). Miniature devices that interface with the skin
over a microscopic area would offer a desirable alternative for
transdermal drug delivery and sampling. The stratum corneum (SC)
of the skin, the main barrier to transdermal delivery, limits the
transport to clinically insuf®cient rates for most biologically active
macromolecules, such as insulin or heparin. In this study, we
describe an electrochemical method to create a microconduit (a
microscopic aqueous pathway extending through the thickness of
the SC) in the skin that should facilitate an unhindered transport
across the skin of any macromolecule.
Several types of physical interventions using ultrasound, laser,
high pressure, and microfabrication have been attempted for
altering the SC. Low-frequency ultrasound was shown to increase
the permeability of human skin by several orders of magnitude to
many drugs, including high molecular weight proteins (Mitragotri
et al, 1995; Kost et al, 2000). Application of 168 kHz continuous
ultrasound of spatially averaged pressure amplitude of 1.9 3 105 Pa
generated defects in human SC specimens (Wu et al, 1998). A mid-
infrared Er:YSGG laser was used to ablate cadaveric swine SC
leading to an increased permeability for H-3-hydrocortisone
(Nelson et al, 1991). A stress pulse generated by a single laser pulse
was shown to increase transiently the permeability of the SC in vivo
with recovery occurring within minutes (Lee et al, 1998). A device
that uses compressed helium gas to accelerate microscopic particles
into the skin was used as a delivery system for DNA vaccines to
elicit a virus-speci®c response in mice (Degano et al, 1998). Silicon-
processed microneedles have been shown to increase permeability
of human skin in vitro (Henry et al, 1998; Lin and Pisano, 1999).
Altea's MicroPor uses thermal energy to vaporize the top layer of
the epidermis within a small, sharply de®ned region to deliver drugs
(Eppstein et al, 1999) and sample interstitial ¯uid (Smith et al, 1999).
Skin electroporation by high voltage pulsing provides an alternative
method for transdermal drug delivery and analyte sampling. In this
study, we report the creation of a microconduit at a known site in
the SC by high-voltage pulsing in the presence of a keratolytic
agent.
Skin electroporation is an extension of lipid bilayer membrane
electroporation (Weaver and Chizmadzhev, 1996), in which a brief
elevation of the transmembrane voltage is hypothesized to create
aqueous pathways (Fig 1, center) across the multilamellar bilayer
membranes of the SC (Weaver et al, 1999a,b). Based on the idea that
electroporation could introduce low-toxicity keratolytic molecules
into the corneocytes through these aqueous pathways, a hypothesis
to create microconduits across SC was developed earlier (Ilic et al,
1999; Weaver et al, 1999b; Zewert et al, 1999). The combination of
new aqueous pathways through the multilamellar lipid bilayer
membranes and disruption of the keratin matrix could result in
dislodgement of entire stacks of corneocytes (Fig 1, right), creating a
minimum size (» 50 mm diameter) microconduit through the SC.
Such an opening would present negligible steric hindrance to
macromolecule transport. By using temporally controlled pressure-
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driven ¯ow, large rates of molecular transport should be achieved, for
both conventional pharmaceuticals and the larger peptides, proteins,
and nucleotides from biotechnology.
Initial experiments (Zewert et al, 1999) using sodium thiosulfate
(STS) as the keratolytic agent showed that a macromolecule
(lactalbumin, » 15,000 g per mol) and smaller, charged molecule
(sulforhodamine, 600 g per mol) were transported at almost the
same rate across heat-stripped human skin in vitro; however, a large
variability in microconduit creation was observed. In a subsequent
study, urea was added to stabilize the STS-reduced (broken)
disul®de bridges reduced, preventing them from reforming by
oxidation (Ilic et al, 1999). It was shown that » 1200 mm2 diameter
microconduit spanning the SC was created following treatment
with STS and urea. The microconduit was shown to support
volumetric ¯ow of order 0.01 ml per s by a pressure difference of
only 0.01 atm (about 102 Pa), demonstrating that the SC barrier had
been completely removed within this microscopic area. Other
studies showed that electroporation could be constrained to occur
at predetermined sites (microholes in an insulating thin sheet) even
with imperfect skin contact (Gowrishankar et al, 1999).
In this study, we investigate the use of active ingredients of
Whit®eld's solution in creating a microconduit in human skin in
vitro. Whit®eld's solution, with established keratolytic properties,
®nds extensive use in the topical treatment of intractable, super®cial
(limited to the SC) dermatophyte infections of the skin (Holti,
1970; Clayton and Connor, 1973; Wright and Robertson, 1986;
Russell and Russell, 1992; Gooskens et al, 1994; Diehl, 1996;
Bennett, 1998). Whit®eld's solution achieves chemical decomposi-
tion of keratin by breaking the keratin peptide bonds and by
reducing the binding forces within the SC, which is likely the basis
for its keratolytic mode of action (Huber and Christopher, 1977;
Gloor and Beier, 1984; Nook, 1987; Neubert et al, 1990; LoÂden
et al, 1995; Budavari, 1996; Lin and Nakatsui, 1998). In this study
we report a rapid, controlled method for creating a microconduit at
a predetermined site in full-thickness human skin, with the
microconduit supporting a pressure-driven ¯ow across isolated SC.
MATERIALS AND METHODS
Microconduit creation procedure This in vitro study involves the
investigation and partial optimization of an electrochemical process for
microconduit creation. The two-step procedure involves:
1 Introduction of keratolytic chemicals into corneocytes at a
predetermined microscopic area site by high-voltage pulsing that
electroporates the multilamellar bilayer lipid membranes (Gowrishankar
et al, 1999). This involves creation of many primary pores (diameter
» 1 nm) within a spatially constrained local transport region by using an
electrically insulating mask with a single » 200 mm microhole that spatially
constrains the current; and
2 Rapid disruption of the keratin matrix within the electroporated
corneocytes by the keratolytic solution.
Skin preparation Adult human skin was secured from the abdomen,
arm, or back of cadavers (NDRI, Philadelphia, PA and Ohio Valley Tissue
and Skin Center, Cincinnati, OH). The skin, stored at ±70°C, was cut into
1 inch (2.54 cm) square pieces and thawed to room temperature prior to the
start of the experiment. The microconduit creation step was carried out
using full thickness skin. The ¯ow test (see section on tests for
microconduit presence below) was carried out on thinned skin, prepared
by heat stripping and/or treated with trypsin.
Heat stripping yields a specimen of thickness 100 6 50 mm. This
procedure involves a well established method of immersing the skin in
» 60°C water for 2 min (Gummer, 1989). In some cases, overnight removal
of the remaining epithelium was achieved by enzymatic trypsin digestion
(Anderson et al, 1988). The heat-stripped skin was digested in 1% trypsin
(Sigma, St Louis, MO, T-0134) for 12 h at 4°C.
Experimental chambers Both high-voltage pulsing during the
microconduit creation phase and iontophoresis thereafter, were carried
out in the top±bottom chamber of Fig 2. The chamber is a modi®ed
version of the side-by-side chamber in which the donor compartment is
masked by a nonconducting polyimide sheet with an approximately
200 nm diameter microhole. A full-thickness skin specimen was mounted
between the two compartments with the SC facing the donor and
contacting the polyimide sheet. The ¯ow test following the creation of a
microconduit (after the skin was thinned) was performed in the side-by-
side chamber of Fig 3.
Electrical pulsing In this study, the total time of the experiment, ttotal,
the interval between pulses, tint, the high-voltage pulse decay constant,
tpulse, and the peak current, I, were selected to deliver a total charge of
about 40 mC during the pulsing protocol. The voltage across the skin,
Uskin, and the total charge transferred, q, were calculated according to Eq 1,
and Eq 2, respectively.
Uskin  Uinner ÿRPBSI  Uinner ÿRPBS Umeas
Rmeas
1
where RPBS is the resistance of the phosphate-buffered saline (PBS) column
between the measuring electrodes (Fig 2) with no skin present in the
chamber. The peak voltage across the measuring electrodes, Uinner, and the
peak current, I, were measured from the exponential waveforms recorded
during high-voltage pulsing. For a measured peak current, I, the total
number of coulombs, q, transferred over the total time is:
Figure 1. Illustration of the hypothesis of microconduit creation
using a modi®ed ``brick wall model'' for human SC. (Weaver et al,
1997, 1998) A single local transport region is depicted, showing only about
one-third of the 15±16 corneocyte layers of the SC. For simplicity, ordered
stacks (columns) of corneocytes (Menton, 1976) are shown. Similar
behavior is expected with disordered (offset) columns (Bergstresser and
Chapman, 1980), because typical corneocyte offsets introduce additional
tortuosity that is about the same as the slight internal tortuosity expected
within an ordered stack. Some of the pathways created by pulsing alone are
hypothesized to be larger than pathways through the unperturbed keratin
matrix (Zewert et al, 1995). Left: Site prior to aqueous pathway creation.
Left center: Site after several high-voltage pulses, depicting a high area
density of straight-through primary pathways within the local transport
region before enlargement by introduction of keratolytic molecules. Right:
Microconduit resulting from removal of most of a weakened stack of
corneocytes after keratin matrix disruption.
Figure 2. Chamber and circuitry used for electrochemical inter-
vention. Both pulsing and measuring electrodes were made of stainless
steel and were 3 cm long. The full-thickness skin was mounted with the SC
contacting the 50 mm thick polyimide sheet containing a 200 mm diameter
microhole. The current through the skin was determined from the voltage
across the 2 W resistor. In all the experiments, the receptor compartment
contained PBS (pH 7.4).
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q  ttotal
tint
1
0
Ieÿt
0=pulse dt0  ttotal
tint
Ipulse 2
High-voltage pulses were applied using an exponential pulser
(Electroporation System 600, BTX Industries, San Diego, CA). A
noninductive, high power rating (25 W) resistor (Rmeas = 2W) was placed
in series with the chamber in order to measure the current through the
skin. The measuring electrodes consisted of stainless steel wires (0.7 mm
diameter, 3 cm long) placed in the inner ports of the chamber parallel to
skin surface, at a distance of 1.5 cm between them (Fig 2). The voltages
across the inner electrodes (Uinner) and the 2 W series resistor during pulses
(Umeas = IRmeas) were stored in a digital oscilloscope (Hewlett Packard
54601) for determining Uskin according to Eq 1.
Keratolytic molecules In this study, we used skin electroporation with
a topically applied solution of keratolytic molecules: salicylic acid (Sigma,
S-0875, 138 g per mol) and benzoic acid (Sigma, B-3250, 122 g per mol).
In most experiments, 3% salicylic acid and 6% benzoic acid were used in a
70% ethanol and 30% PBS (pH 7.4) solution. These chemicals, in the
concentrations mentioned above, form the active ingredients of Whit®eld's
solution, which is a well-established topical medication with keratolytic
activity.
Fluorescent molecules Sulforhodamine (Sigma; 607 g per mol; z = ±1;
``red ¯uorescence''; 0.5 mM in donor compartment) was used as a
¯uorescent tracer, because it is both water soluble and suf®ciently
lipophylic that it also stains cell membranes (Chen et al, 1998), allowing
tissue accessed by the microconduit to be stained. The sulforhodamine
molecule size is about 1.5 nm, which allows it to be readily transported
through the primary aqueous pathways (about 2 nm diameter) created by
high-voltage pulsing, and to pass with negligible steric hindrance through
the intact keratin matrix within corneocytes.
A 2.5% volume suspension of ¯uorescent latex beads (Fluoresbrite,
``green ¯uorescence''; Polysciences, Warrington, PA; 1.5 mm diameter)
with a large negative charge (» ±8 3 10±12 C) was used. These microbeads
are much larger than typical macromolecules, and can often be detected
individually by ¯uorescence microscopy. Such beads do not penetrate the
skin due to high-voltage pulsing alone (Chen et al, 1999), owing to both
their large charge and size.
Positive control To assess microconduit creation, electrochemically
treated full thickness skin specimens were ®rst evaluated by four indicators
that were established in positive control experiments. In these experiments,
an approximately 200 mm diameter shallow microhole was drilled through
the SC of a full thickness skin specimen by a cobalt microprecision drill bit
(GuÈhring, Brook®eld, WI). The skin specimen was then subjected to
iontophoresis with PBS containing ¯uorescent markers in the donor side
(contacting the SC). The rationale was that a small, constant current
preferentially transports these negatively charged markers into the low
resistance microhole, thereby marking it for optical microscopy.
Negative control Negative control experiments were performed on
unperturbed full thickness skin. The skin specimen was mounted in the
top±bottom chamber (Fig 2) with the donor compartment containing
¯uorescent markers in PBS. The skin was subjected to iontophoresis with
the same electrical parameters as in an actual experiment involving
electrochemical treatment.
Iontophoresis control Iontophoresis control experiments refer to direct
(low-voltage) current treatment of full thickness skin in the presence of
keratolytic molecules. The skin specimen was mounted in the top±bottom
chamber (Fig 2) with the donor compartment containing 3% salicylic acid
and 6% benzoic acid in 70% ethanol and 30% PBS solution. The skin was
subjected to 1 mA per cm2 (over the area of a microhole in the insulating
sheet, i.e., J = I/Amhole) iontophoresis for 1 h. Following the treatment, the
donor solution was replaced with the ¯uorescent marker solution and the
iontophoresis procedure was repeated for 1 h.
Pulsing control Pulsing control experiments relate to the electrical
treatment of the skin without the use of keratolytic molecules. The skin
was mounted in the top±bottom chamber (Fig 2) with the donor
compartment containing PBS only, or 70% ethanol and 30% PBS. The
skin was subjected to high-voltage pulsing and iontophoresis in the
presence of ¯uorescent markers with the same electrical parameters as in an
actual experiment involving electrochemical treatment with keratolytic
molecules. Note that because the PBS solution has a lower electrical
resistance than the 70% ethanol + 30% aqueous solution, a larger fraction of
the applied voltage appears across the skin. The importance of this ``variable
voltage divider'' effect is discussed elsewhere (Weaver et al, 1998; Pliquett
1999; Pliquett et al, 2000).
Experimental procedure The experimental procedure involved in the
electrochemical creation of a microconduit and in the tests to con®rm its
presence is described below.
1 A previously thawed full-thickness human cadaver skin specimen was
mounted in the top±bottom chamber (Fig 2), avoiding visible skin
deformation by excessive pressure. The integrity of the skin was
evaluated by measuring the initial skin electrical resistance between the
pulsing electrodes.
2 In positive control experiments, a 200 mm microhole, approximately
40 6 20 mm deep, was drilled in the skin. In negative control experiments,
the skin was left unperturbed. In microconduit creation experiments, the
donor compartment was ®lled with the keratolytic solution and the high-
voltage pulsing protocol followed.
3 In order to transport negatively charged ¯uorescent markers electrically,
1 h of 1 mA per cm2 iontophoresis was applied (over the region of the skin
exposed to the microhole in the insulating sheet) with the donor containing
the two ¯uorescent markers in PBS. The ®nal skin resistance was measured
following iontophoresis.
4 The skin was then examined by optical microscopy using both
incandescent and ¯uorescent illumination. Further imaging and ¯ow tests
were performed after the skin was heat stripped, and in some cases, further
treated with trypsin. Thus thinned skin was mounted in the side-by-side
chamber (Fig 3) with a column of aqueous solution on the donor side. The
¯ow was recorded at various time intervals as the decrease in the column
level.
Tests for microconduit presence The creation of a microconduit was
assessed using three independent tests: the resistance ratio test, the imaging
tests, and the pressure-driven volumetric ¯ow test. The ®rst test was applied
to full-thickness skin, the last test was applied after the skin was thinned by
heat stripping (Gummer, 1989) or heat stripping and enzymatic (trypsin)
digestion of the epidermis, the combination yielding isolated SC (Anderson
et al, 1988). The second test was applied to both full-thickness and thinned
skin specimens.
Resistance ratio test High-voltage pulsing and the use of keratolytic
molecules create SC spanning aqueous pathways in the skin. This change in
skin structure is re¯ected partially by a change in skin resistance. An LCR
meter (SR715, Stanford Research Systems, Sunnyvale, CA) was used to
measure the real part of the low frequency skin impedance (100 mV,
100 Hz sinusoidal input). A parallel RC model was assumed for the skin.
Because the capacitance of the skin changes very little following high-
voltage pulsing, the transdermal resistance, Rskin, dominates the skin
impedance. The decrease in Rskin following treatment was quanti®ed by
the resistance ratio fR, de®ned as
fR  R
i
skin
Rfskin
3
Figure 3. Chamber used in ¯ow experiments. The electrochemically
treated skin, after thinning by either heat stripping and/or treatment with
trypsin, was mounted in the chamber with the SC facing the donor
compartment. A column of aqueous solution was added to the donor
compartment in order to establish a hydrostatic pressure difference across
the skin. The presence of a microconduit in the skin resulted in a
continuous decrease in the level of the aqueous column. The column
height, h, was recorded at a number of time points and used in ¯uid ¯ow
analysis to estimate the diameter of the microconduit.
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where Riskin and Rfskin are the initial and ®nal skin resistances, measured
before and after the treatment, respectively. The resistances were corrected
for a baseline resistance that accounted for the resistance of the PBS
between the measuring electrodes and the resistance of the electrodes. The
baseline resistance was measured at the end of each experiment with no
skin present in the chamber. A large, persisting change in skin resistance
was used as an indicator for the creation of a microconduit.
Imaging test To assess the creation of a microconduit, full-thickness
skin specimens were ®rst evaluated by imaging using incandescent and
¯uorescence microscopy. Then, imaging was repeated following heat
stripping, and again following treatment with trypsin to con®rm the
creation of a microconduit.
After the brief electrochemical procedure, the skin specimen was
subjected to iontophoresis in the presence of PBS containing sulforhoda-
mine and ¯uorescent beads. The rationale is that a small, constant current
preferentially drives these markers into the low resistance microconduit,
thereby marking it identi®able by optical microscopy. On completion of
high-voltage pulsing and iontophoresis, the skin was removed from the
chamber and rinsed with de-ionized water. The skin was mounted on a
microscope slide and examined under a ¯uorescence microscope (Olympus
BH-2, Olympus, Woodbury, NY). The ¯uorescent image of the skin was
acquired using a CCD camera (Pixera, Los Gatos, CA). Imaging was also
carried out further at two stages: after heat stripping and (in some cases)
after further treatment by enzymatic trypsin digestion. An incandescent
(white) light source was placed below the specimen, with observation from
above. As light passes through the microconduit, the opening in the skin
appears as a single, bright spot surrounded by a dark region of intact skin.
Pressure-driven volumetric ¯ow test The most direct, functional
evidence for the presence of a microconduit is a measurable volumetric
¯ow. Thus, a pressure driven ¯ow across the electrochemically treated skin
was used as a test for the presence of a microconduit. Either the heat-
stripped skin or the enzymatically isolated SC was mounted in the side-by-
side chamber (Fig 3). Pressure-driven ¯ow was then measured by
establishing a hydrostatic pressure difference between the two
compartments of the chamber, using a vertical column of up to 12 cm
aqueous solution on the donor side. Volumetric ¯ow was measured by
recording the height of the solution column meniscus as a function of time,
t, and multiplying by the cross-sectional area of the column to obtain the
volume accumulation with time.
Well-established ¯uid dynamics equations (White, 1979) were used to
relate the diameter, DMC of the microconduit with the coef®cients
obtained from the least square ®t of a polynomial a1t2 + a2t to the
experimental data points for the ¯uid volume change with time, V(t). The
microconduit diameter DMC was calculated assuming ¯uid ¯ow through an
ori®ce as
DMC  32a1Acol0:6
g2
 1=4
4
Here, Acol is the cross-sectional area of the column of aqueous solution,
g = 9.8 m per s2 is the local value of the earth's gravitational acceleration,
and 0.6 is the aqueous solution coef®cient of velocity for a short tube
approximation (White, 1979), which is appropriate for a » 200 mm
diameter microconduit with a thickness ranging from » 20 mm (isolated
SC) to » 100 6 50 mm (heat-stripped skin).
RESULTS AND DISCUSSION
The motivation of this in vitro study is to investigate the ef®cacy of
the ethanol, salicylic acid and benzoic acid solution in creating a
microconduit in the SC of human skin. The presence of a
microconduit was assessed using three independent tests. The
results of these tests are summarized in Tables I and II, and Figs 4±
9. Based on positive control results, four features were identi®ed as
indicators of the presence of a microconduit:
1 fR, the resistance ratio, which represents the change in skin
resistance from the initial, unperturbed state to that following the
electrochemical treatment. The presence of a microconduit causes a
large increase in fR.
2 Macro Focus: macroscopic focusing, is the presence of a
focused spot on the skin at the site where the microhole of the
chamber contacted the skin, as seen in the macroscopic view of the
skin. When a microconduit is created using the electrochemical
treatment, sulforhodamine present in the donor solution enters the
microconduit to form a red ¯uorescent spot approximately equal in
dimension to the microhole in the insulating sheet.
3 Micro Focus: microscopic focusing, is the presence of a focused
cluster of negatively charged ¯uorescent microbeads at the site of
the microconduit. If a microconduit is created following the
electrochemical treatment, iontophoresis of the skin with highly
charged ¯uorescent beads in the donor compartment causes the
beads to be clustered in the microconduit.
4 Vert Pool: vertical pooling, denotes the pooling of the beads
throughout the depth of the SC (» 20 mm) if a microconduit is
created in the skin. The vertical pooling of ¯uorescent beads is
determined by acquiring ¯uorescent images of the skin at various
depths.
A large value of fR accompanied by the presence of the
remaining three indicators strongly indicates the presence of a
microconduit following the electrochemical procedure. The
presence or absence of optical indicators is denoted by + or ±,
respectively, in Table I.
Figures 4±8 display the results of different control and
electrochemical treatment procedures on full-thickness human
skin. The top left panel shows the macroscopic view of the skin.
The top center and top right images are ¯uorescent images of the
skin at different depths (30 mm apart). The bottom panels show
¯uorescent images of the skin at a higher magni®cation, acquired at
different depths, 5 mm apart.
Negative controls Five negative control experiments were
performed on unperturbed full-thickness skin exposed to either
Table I. Results of resistance ratio and optical testsa
Salicylic
acid
Benzoic
acid
Uskin
(V)
tpulse
(ms)
tint
(s)
ttotal
(s)
I
(mA)
q
(mC)
fR Macro
focus
Micro
focus
Vert pool
Negative controls (n=5): unperturbed skin with PBS in donor 461 ± ± ± Fig 4
Negative controls (n=5): skin with 70% ethanol in donor 361 + ± ±
Positive controls (n=5) 1662 + + + Fig 5
PBS (n=5) 195 10 3 300 40 40 662 ± ± ± Fig 6²
70% Ethanol (n=5) 260 5 5 600 60 36 1061 + ± ±
0.3% 0.6% 260 5 5 600 64 38 1061 + ± ±
3% 6% 237 3.6 5 485 65 22 26 + + +
3% 6% 217 5 5 600 50 30 32 + + +
3% 6% 279 5 5 600 55 33 40 + + +
3% 6% 250 5 5 600 62 37 49 + + + Fig 7
aNote that in all experiments, following either control exposure, mechanical microhole creation, or electrochemical intervention, the skin was subjected to 1 h
iontophoresis at 1 mA per cm2 (over the area of the microhole in the polyimide sheet) before indicators were ascertained. Four indicators were derived from resistance ratio
and optical tests. These are denoted by fR (resistance ratio), Macro Focus (macroscopic focusing), Micro Focus (microscopic focusing), Vert Pool (vertical pooling), and are
described in the text. Some of the results are accompanied by images indexed in the right-hand column. ``²'' indicates the pulsing only controls (n = 5). Presence/absence
of optical indicators are denoted by +/±.
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PBS only or to 70% ethanol and 30% PBS. The skin was subjected
to iontophoresis in the presence of the ¯uorescent markers for the
same duration as in an experiment with electrochemical treatment.
The resistance ratio was 4 6 1 (PBS only) and 3 6 1 (70% ethanol
and 30% PBS) following iontophoresis (Table I). Iontophoresis of
unperturbed skin did not cause a focused clustering of beads at the
site of the microhole and the beads did not persist throughout the
depth of SC (Fig 4), i.e., Micro Focus and Vert Pool were
negative, respectively. The macroscopic view of the skin did not
show a focused spot where the skin contacted the microhole in the
polyimide sheet, when exposed to PBS only. When exposed to
70% ethanol, Macro Focus was positive, indicating minor
perturbation of lipids of SC, allowing binding of sulforhodamine.
Iontophoresis controls Five iontophoresis control experiments
were performed on full-thickness skin exposed to 1 h of 1 mA per
cm2 iontophoresis in the presence of salicylic acid and benzoic acid.
The resistance ratio following the treatment was 4 6 2 (Table I).
Figure 5. Iontophoresis control. The skin was
subjected to iontophoresis for 1 h with Whit®eld
solution's ingredients in the donor compartment.
Top left image is the macroscopic view of the skin
showing a focused spot stained by sulforhodamine.
The top center and top right images are ¯uorescent
images of the skin taken at different depths
(30 mm apart). The bright spots, which represent
¯uorescent beads, indicate only discrete binding of
beads to the skin. There is no cluster of ¯uores-
cent beads present in the skin. The dark region
represents staining of the skin by sulforhodamine.
The bottom images are ¯uorescent images of the
skin at a higher magni®cation. The images are
taken at different depths, 5 mm apart. The disjoint
presence of beads is clearly visible suggesting that
there is microconduit in the skin.
Table II. Results of further imaging and ¯ow testsa
Salicylic
acid
Benzoic
acid
Uskin
(V)
tpulse
(ms)
tint
(s)
ttotal
(s)
I
(mA)
q
(mC)
fR MC
visualized
Fluid
¯ow
3% 6% 249 5 5 600 57 34 43 ± +
3% 6% 273 5 5 600 61 37 39 ± +
3% 6% 241 5 5 600 64 38 35 ± +
3% 6% 299 5 5 600 58 35 42 + +
3% 6% 228 5 5 600 60 36 46 + +
3% 6% 240 5 5 600 67 40 47 + + Figs 8, 9
aThe skin in these experiments was heat stripped and/or treated with trypsin overnight following the electrochemical process of microconduit (MC) creation. The entries
in this table are similar to those in Table I. Two de®nite con®rmations of a microconduit are listed here for each experiment. MC visualized relates to whether the MC
was visualized by optical microscopy, either after heat stripping or treatment with trypsin. Fluid ¯ow indicates whether a ¯uid ¯ow was observed in the pressure-driven
¯uid ¯ow test after treatment with trypsin. Presence/absence of de®nite con®rmations are denoted by +/±.
Figure 4. Negative control. A full thickness
human skin was subjected only to iontophoresis
for 1 h with sulforhodamine and ¯uorescent beads
suspended in saline in the donor compartment.
Top left is the macroscopic view of the skin. The
black ellipse encompasses the site of the polyimide
microhole that contacted the skin. No extensive
staining of the skin by sulforhodamine is evident.
The top center and top right images are ¯uorescent
images of the skin taken at different depths
(30 mm apart). The bright spots, which represent
¯uorescent beads, indicate discrete binding of
beads to the skin. There is no cluster of ¯uores-
cent beads present in the skin. The dark region
represents staining of the skin by sulforhodamine.
The bottom images are ¯uorescent images of the
skin at a higher magni®cation. The images are
taken at different depths, 5 mm apart. The disjoint
presence of beads is clearly visible. The beads do
not persist over a large depth suggesting that there
is no pathway spanning the SC in the skin.
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Following the treatment, the skin was subjected to another 1 h of
iontophoresis with the ¯uorescent dye solution in the donor
chamber. Iontophoresis of unperturbed skin did not cause a focused
clustering of beads at the site of the microhole and the beads did not
persist throughout the depth of SC (Fig 5), i.e., Micro Focus and
Vert Pool were negative, respectively; however, the macroscopic
view of the skin showed a focused spot where the skin contacted
the microhole in the polyimide sheet (Fig 5). It is clear that
iontophoresis treatment alone is not suf®cient to transport the
keratolytic molecules into the corneocytes to create a microconduit
in the skin.
Positive controls In ®ve positive control experiments, an
approximately 200 mm diameter hole through the SC and about
40 6 20 mm deep was created by a cobalt microprecision drill bit in
full-thickness human cadaver skin. The skin specimen was then
subjected to iontophoresis with PBS containing ¯uorescent markers
in the donor compartment (contacting the SC). Following the
creation of a hole in the skin, fR was 16 6 2, indicating the presence
of new aqueous pathways in the skin. In addition, all three optical
indicators were present (Table I). A well-de®ned spot was visible
in the skin, stained red (¯uorescence) by sulforhodamine in the
donor solution (Fig 6, top left; this represents Macro Focus). The
¯uorescence image of the skin also revealed a dense cluster of
¯uorescent beads in the spot (Fig 6, top right; this represents Micro
Focus). The cluster of beads persisted as the plane of view was
moved deeper than 15 mm from the SC surface (Fig 6, bottom; this
represents Vert Pool). The small, constant iontophoresis current
preferentially had driven the beads into the low resistance
microhole.
Pulsing control Two types of pulsing controls were performed.
In the ®rst case, the donor compartment contained PBS whereas in
the second case, the donor compartment contained 70% ethanol in
PBS. In both cases, the skin was subjected to high-voltage pulsing
and iontophoresis, but without any keratolytic molecules in the
donor solution.
When the skin was pulsed in the presence of PBS, with 40 mC of
charge delivered, the resistance ratio increased to 6, similar to an
increase to 4 in the negative control experiments (Table I). As in
the negative control experiments, all three optical indicators were
negative. The ¯uorescence image of the skin showed no areas with
clustered beads, only scattered beads were visible (Fig 7). These
indicators suggest that high-voltage pulsing alone causes no
disruption to the keratin matrix and therefore does not create a
microconduit in the SC.
When the skin was pulsed in 70% ethanol, the resistance ratio
increased to 10 6 1 when the total charge delivered was 36 mC.
The macroscopic view of the skin showed a focused red spot at the
site of the microhole. The other two ¯uorescent indicators were
negative. The presence of ethanol during high-voltage pulsing only
marginally increased the permeability of SC and thus the
appearance of a sulforhodamine-stained spot on the skin due to
increased access to lipids.
Figure 7. Pulsing control. A full-thickness skin
specimen was subjected to high-voltage pulsing
and iontophoresis (Table I, third row) with only
PBS and ¯uorescent markers in the donor com-
partment during high-voltage pulsing and ionto-
phoresis, respectively. Top left image (macroscopic
view) shows no focused red spot. The low-magni-
®cation ¯uorescent images (top center and top right;
30 mm apart in depth) show no areas with large
density of ¯uorescent beads. Similarly, the magni-
®ed ¯uorescent images (bottom panel, 5 mm apart in
depth) show only a scattered, distribution of
¯uorescent beads. These images suggest that there
was no extensive keratin disruption following
high-voltage pulsing when keratolytic agents were
absent during high-voltage pulsing.
Figure 6. Positive control. A shallow » 200 mm
hole was drilled into the full-thickness skin using a
cobalt microprecision drill. The skin was then
subjected to iontophoresis for 1 h in the presence
of sulforhodamine and latex beads suspended in
PBS in the donor compartment. The top left image
shows the macroscopic view of the image follow-
ing iontophoresis. A focused red (here dark) spot
(denoted Macro Focus in Table I) is seen (arrow)
at the site where the skin came into contact with
the microhole in the chamber. Top center and top
right images are ¯uorescent images of the skin,
imaged 20 mm apart in depth. The images show a
dense cluster of ¯uorescent beads at the site of the
microhole (denoted Micro Focus in Table I).
Images in the bottom panel show the ¯uorescent
images at a higher magni®cation, separated by
15 mm in depth. The cluster of ¯uorescent beads
persists over more than 15 mm in depth (denoted
Vert Pool in Table I). Contrast to the negative
control experiments, the beads are not distributed
as individual beads, they are instead clustered
within the microhole.
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Electrochemical creation of a microconduit The main
objective of this study is to characterize the use of high-voltage
pulsing and two pathway-enlarging molecules to create a
microconduit in human skin. The parameters of high-voltage
pulsing and concentrations of the keratolytic chemicals were varied
to optimize the process of microconduit creation.
Pulsing control experiments demonstrated that high-voltage
pulsing alone does not disrupt the keratin matrix. Salicylic acid and
benzoic acid are present in concentrations of 3% and 6% in
Whit®eld's solution. Electrochemical treatment of full-thickness
skin with 1/10th this concentration did not reveal the presence of a
microconduit. Only one of three optical indicators was positive
(Table I). Although the skin showed a macroscopic red spot
indicating sulforhodamine staining of the ethanol altered lipids, no
cluster of ¯uorescent beads was found in the red spot. Following
the treatment, fR increased to » 10 6 1, less than that observed in
positive control experiments. This suggests that the concentrations
of the keratolytic components were not high enough to cause an
enlarged pathway in SC.
As a low concentration of keratolytic agents did not enlarge
pathways created by high-voltage pulsing, the remaining experi-
ments were conducted at concentrations present in Whit®eld's
ointment. Thus, during the electrochemical intervention, the
donor compartment contained 3% salicylic acid and 6% benzoic
acid in 70% ethanol with two ¯uorescent markers. The results of
these experiments are tabulated in the last four rows of Table I.
Electrochemical treatment of full-thickness human skin with 3%
salicylic acid and 6% benzoic acid consistently created a micro-
conduit in SC. This was ascertained from resistance ratio and
imaging tests. All three imaging indicators were positive in these
experiments. The resistance ratio, following electrochemical
intervention, ranged from 26 to 49 (Table I, last four rows).
These values are higher than even that measured in positive control
experiments. This strongly supports the presence of an enlarged
aqueous pathway in the treated skin.
Figure 8 shows the images of a full-thickness skin specimen
following electrochemical treatment. In the macroscopic view (top
left), a well-de®ned red spot is clearly seen at the site where the skin
contacted the microhole in the polyimide sheet. The red spot
Figure 9. Visualization of a microconduit. A
full-thickness skin was subjected to a 10 min
electrochemical process (Table II) in the presence
of sulforhodamine. Top left image shows the
macroscopic view of the skin, with a focused red
(here dark) spot formed by sulforhodamine stain-
ing of the microconduit (arrow). Top right is the
corresponding ¯uorescent image, which shows the
presence of sulforhodamine in the microconduit
(seen as dark regions in the gray-scale image). The
skin was then heat stripped to get a thinned speci-
men. Bottom left shows the ¯uorescent image of
the heat-stripped skin. The central bright region is
the region of the skin that contacted the micro-
hole in the polyimide sheet. The bottom right is an
incandescent image of the heat-stripped skin, illu-
minated from below using a bright light source.
The microconduit in the skin (enclosed by the
white circle) is brightly illuminated by light pass-
ing through the microconduit in the skin. This
image provides the most striking optical evidence
of the presence of a microconduit in the skin.
Figure 8. Electrochemical creation of a
microconduit. A full-thickness skin specimen
was subjected to a 10 min electrochemical treat-
ment involving 3% salicylic acid and 6% benzoic
acid in 70% ethanol and 30% PBS (Table I). The
electrochemical protocol is followed by ionto-
phoresis for 1 h at 1 mA per cm2 in the presence
of large latex beads and sulforhodamine. The
macroscopic view of the skin (top left) shows a
focused red spot at the site of microhole contact.
The ¯uorescent images (top center and top right;
20 mm apart in depth) show a dense cluster of
¯uorescent beads. The ¯uorescent images at
higher magni®cation (bottom panel; 15 mm depth
intervals) also show a cluster of beads that persist
over 20 mm deep. These images relate to positive
indicators, labeled Macro Focus, Micro Focus, and
Vert Pool in Table I. The features in these images
are essentially the same as those obtained in posi-
tive control experiments (Fig 5). The results sug-
gest that a SC-spanning microhole has been
created in the full-thickness skin following
electrochemical treatment.
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results from the staining of sulforhodamine, which now ®nds access
to corneocytes deeper into the skin (Macro Focus positive). The
¯uorescence images of the skin (top center and top right) show a
dense cluster of ¯uorescent beads in the microconduit (Micro
Focus positive). Iontophoresis following the microconduit creation
phase of the protocol concentrates the charged beads at the site of
the lowest resistance, i.e., the microconduit. The ¯uorescence
images of the skin at a higher magni®cation (bottom panels) show
that the cluster of ¯uorescent beads persists over 20 mm in depth
from the surface of the SC (Vert Pool positive). This provides
strong evidence that a microconduit has been created that spans the
SC following treatment with the keratolytic chemicals.
Direct comparison of the results associated with an electro-
chemically created microconduit using indicators observed in
``positive controls'' were used to establish tentative conditions for
microconduit creation; however, the degree of keratin disruption is
not easily ascertained using these indicators. Hence in the next six
experiments listed in Table II, the full-thickness skin was thinned
after electrochemical treatment either by heat stripping alone or by
treating the heat-stripped skin with trypsin. Imaging and ¯ow tests
on thinned skin provided con®rmatory evidence of the presence of
a microconduit (Figs 9 and 10).
In Fig 9, the top panels (left and right) show macroscopic and
microscopic views of the sulforhodamine-stained skin after the
electrochemical protocol. The bottom images were acquired after
skin thinning. The heat-stripped skin shows a red spot (the light
gray region in Fig 9, bottom left) at the site of microhole indicating
the sulforhodamine staining of the region exposed to the
electrochemical treatment. When heat-stripped skin is exposed to
incandescent light from below, a bright region is seen at the site of
the microconduit (Fig 9, bottom right). This provides a strong
evidence that a microconduit spanning the SC has been created,
which allows light to pass through.
More striking evidence of a microconduit is provided by the
¯ow tests on skin treated with trypsin following the electrochemical
treatment. Treatment with trypsin leaves mostly the SC, therefore a
microconduit spanning the SC should support a measurable ¯ow.
Pressure-driven ¯ow was measured by establishing a small
hydrostatic pressure difference between the two compartments of
the chamber, using a vertical column of up to 12 cm aqueous
solution on the donor side. Figure 10 shows the volume of solute
transported through the microconduit as a function of time. The
measured ¯ow was compared with ®t to theoretical model (Eqn 4)
to estimate the size of the microconduit. The best ®t estimate for
the microconduit diameter of the specimen shown is 200 6 20 mm.
This dimension, along with the resistance ratio values and other
four indicators, is similar to that observed in positive control
experiments.
The striking con®rmatory evidence for the presence of a
microconduit was obtained from the volumetric ¯ow test. Fluid
¯ow was consistently observed in all six different electrochemical
treatments (Table II), even in the isolated SC cases where
microconduit could not be directly visualized (microconduit
visualized negative). The heat-stripping procedure leaves a variable
number of epithelial layers attached to the SC, which prevents light
from passing through a microconduit spanning only the SC.
Treatment with trypsin removed the epithelium, leaving only the
SC; however, the resulting preparation is too thin to provide an
optical contrast between the microconduit and the rest of the intact
SC. In such conditions, a microconduit is dif®cult to visualize
directly. A pressure-driven ¯ow alone provides reliable evidence
for the presence of a microconduit. The ¯ow test indicates that the
electrochemical procedure used in this study creates microconduits
in the range of 200 mm, which support ¯uid transport in the order
of 0.01 ml per s.
Keratolytic molecules Previous experiments (Zewert et al,
1999) using STS showed that a macromolecule (lactalbumin,
» 15,000 g per mol) and » 1 mm charged beads were transported
through microconduits in heat-stripped skin; however, a large
variability in microconduit creation was observed in these
experiments. A following study (Ilic et al, 1999) employed STS
with urea to achieve a more controlled microconduit creation. The
use of urea as an alkylating agent prevented the oxidation of
disul®de bridges reduced by STS. In this study, another solution
known for its keratolytic potential was used to create
microconduits.
Both salicylic acid and benzoic acid are small, and are easily
introduced into corneocytes by electroporation. high-voltage
transdermal voltage pulses create new, small aqueous pathways
(``pores'') in the multilamellar lipids of the SC, thereby providing
salicylic acid and benzoic acid with entry points into corneocytes.
During pulsing, these chemicals are electrically driven into
corneocytes within a local transport region. Salicylic acid degrades
the keratin within electroporated corneocytes, thereby greatly
decreasing the steric hindrance over the localized area of the skin
exposed to the chemicals and high-voltage pulses (Fig 1). This
results in a greatly enlarged aqueous pathway, namely, a
microconduit spanning the SC. In this study, partially optimized
protocol lasting about 5 min was needed to create a microconduit.
Salicylic acid is routinely used to degrade and extract keratin.
Salicylic acid and benzoic acid, active ingredients of Whit®eld's
solution, achieve the chemical decomposition of keratin by
breaking the keratin peptide bonds and by reducing the binding
forces within the SC and ®nd wide applications in treatment of skin
ailments. In our protocol, the skin is exposed to a small amount of
salicylic acid and benzoic acid over a microscopic region for less
than 5 min. This level of exposure is considerably lower than that in
established applications of Whit®eld's ointment. Hence, we expect
no toxic effects to result from the electrochemical treatment
reported here.
Localization of SC disruption An insulating sheet with a
microhole was used in contact with the SC to limit the
electrochemical intervention to a very small area of the skin. As
shown previously, even without a perfect seal, such a masking
causes localized electroporation at the microholes (Gowrishankar
et al, 1999). Electrochemical treatment through a 200 mm
microhole in the polyimide sheet was shown to create a
200 6 20 mm diameter microconduits spanning the SC. A simple
extension of this result suggests that a reduction in the size of the
masking microhole would result in a smaller microconduit.
Figure 10. Volume vs time due to pressure-driven volumetric ¯ow
through a microconduit. The heat-stripped skin of Fig 8 was treated
with trypsin overnight to obtain an isolated SC preparation. The skin was
mounted in the side-by-side chamber with a hydrostatic pressure column
(Fig 2). The pressure difference caused a ¯ow through the microconduit in
the skin. The decrease in the aqueous column height was recorded as a
function of time (indicated by s and * for two independent data sets). A
theoretical ®t to the ¯ow data (Eq 4) is shown by the solid line, yielding a
microconduit diameter of 200 6 20 mm.
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Aqueous pathway creation time The protocol used in this
study provides a reliable creation of a microconduit with a 10 min
(ttotal = 600 s) electrochemical intervention; however, the
cumulative electrical exposure is much shorter, less than 1 s. If
only an electrical exposure in the presence of the keratolytic
molecules is needed to create a microconduit, the present protocol
might be shortened to a very rapid (less than 1 s) procedure;
however, the role of the extra incubating period of the irreversible
degradation of the keratin matrix is not yet established.
Microfabrication of transdermal aqueous pathways Mini-
ature devices that interface with biologic systems over a
microscopic area are being designed both for drug delivery and
sensing. Systems based on gas generation by an electrolytic reaction
(O'Keefe et al, 1994) and on a shape memory actuated microvalve
system (Reynaerts et al, 1996) have been developed and tested for
liquid drug delivery. A Microelectromechanical system for drug
delivery using iontophoresis has been reported recently (Wouters
and Dinh, 1997). Of late, there has also been an increasing interest
in ¯ow type biosensing devices, which take up samples at a constant
rate and perform an in situ or in vivo monitoring (Steenkiste et al,
1997). Our study provides a method for rapidly microengineering a
pathway in the skin to interface future devices for delivery and
sampling of biologically relevant ¯uids.
Localized physical perturbations One classic example is track-
etched ®lter fabrication (Nucleopore), in which penetrating
ionizing particles create a damage track through a polycarbonate
thin sheet, followed by chemical etching along the damage track.
Another is the widespread use of photolithography in
semiconductor fabrication, where physical masks control which
regions are exposed to various kinds of light, and after selected
regions experience photodamage to material such as photoresist, a
chemical etch removes material from targeted regions. We view the
in situ creation of a microconduit as an analogous process: localized
high-voltage pulsing creates localized aqueous pathways, through
which keratolytic ions or molecules are introduced, leading to
selective removal of material to create a microconduit. This analogy
is illustrated in Fig 11.
The creation of a SC-spanning microconduit that encompasses a
microscopic area of the skin may enable the miniaturization of all
the elements of a transdermal drug delivery system while providing
an acceptable level of transport. A spatially localized intervention
may lead to acceptable levels of sensation and unobtrusiveness,
which are essential for the widespread application of a medical
system.
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